Drug intelligence / Profile preview

betacetylmethadol

Development stage
Phase 3
Lead developer
Ningbo Newbay Technology Development
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Administration
Oral (inferred From Class; Specific Data Not Found)
01

Overview

Betacetylmethadol is a synthetic opioid analgesic and a diastereoisomer of alphacetylmethadol and levacetylmethadol. It acts as a narcotic analgesic with a long onset and duration of action. Betacetylmethadol has been investigated mainly for the treatment of narcotic dependence but is not approved for medical use in the United States or other major markets. It is classified as an experimental and illicit substance with no currently accepted medical use due to its high potential for abuse. Mechanistically, like other opioids in its class, it acts primarily as an agonist at opioid receptors[1][2][3][4].

Other names
betacetylmethadolbetacemethadonbetacetilmetadolbetacetilmetadolobetacetylmethadolum
02

Targets

MOR (Mu opioid receptor)

Beyond the preview

Go deeper on betacetylmethadol.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on betacetylmethadol.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call